logo-loader
viewDebenhams PLC

Debenhams confirms it is working with advisers to assess “longer term options”

Press speculation over the weekend hinted the retailer might be looking at a company voluntary arrangement, but there was no direct mention of that in this afternoon’s short statement

debenhams store
Like most high street retailers, Debenhams has struggled over the past couple of years

Struggling high street retailer Debenhams PLC (LON:DEB) has confirmed press speculation that it is working with advisers on “longer term options”.

The company’s shares lost almost a fifth of their value on Monday morning after weekend reports suggested Debenhams had brought in advisers from KPMG to explore a number of options, including a possible company voluntary arrangement (CVA).

READ: Debenhams drops on press speculation

In response to the speculation, Debenhams said it has been working with its advisers since the summer. It also gave a brief overview of its recent performance and outlook, but there was no mention of a CVA.

“As we stated in June, the board continues to work with its advisers on longer term options, which include strengthening our balance sheet and reviewing non-core assets,” said chairman Ian Cheshire.

The struggling department stores operator is due to publish its annual results next month, when it expects to report an adjusted pre-tax profit of £33mln and underlying earnings (EBITDA) of £157mln. Net debt is forecast to come in at around £320mln.

There were mixed messages on market conditions, with chief executive Sergio Bucher stating that the “environment remains challenging and [that] underlying trends deteriorated through the summer months”.

That contrasted the body of the statement itself, which said the early weeks of the new season “have shown more positive trends”.

Getting ready for Christmas

Bucher added that a number of initiatives to boost sales which it had been testing were now ready to be scaled up ahead of the peak Christmas trading period.

“Having put in place a leaner operational structure and strong leadership team, and taken action to strengthen our financial position, we are well equipped to navigate these market conditions and take advantage of any trading opportunities that emerge,” said Bucher.

The statement failed to reverse the earlier losses, with the shares remaining 16% down at 10.8p.

Quick facts: Debenhams PLC

Price: - -

LSE:DEB
Market: LSE
Market Cap: -
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Summit Therapeutics' Glyn Edwards talks US$50mln backing and ridinilazole...

Summit Therapeutics PLC's (LON:SUMM, NASDAQ:SMMT) CEO Glyn Edwards sat down with Proactive London's Andrew Scott following the news of a US$50mln funding deal with biotech billionaire Bob Duggan. The investment will help get the company’s next-generation antibiotic through phase III clinical...

8 hours, 39 minutes ago

2 min read